Rovafovir etalafenamide Uses, Dosage, Side Effects and more
Rovafovir etalafenamide is under investigation in clinical trial NCT03472326 (Efficacy of GS-9131 Functional Monotherapy in HIV-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen).
| Attribute | Details |
|---|---|
| Trade Name | Rovafovir etalafenamide |
| Generic | Rovafovir etalafenamide |
| Rovafovir etalafenamide Other Names | Rovafovir etalafenamide |
| Type | |
| Formula | C21H24FN6O6P |
| Weight | Average: 506.431 Monoisotopic: 506.147897678 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
